Close Menu

One a Week

WashU's David Dooling tells O'Reilly Radar's James Turner about all the genome sequencing work going on at his university, where scientists can now sequence a human genome with complete coverage in a week. "Now with 35 to 40 machines, we can generate lots of sequence on lots of different humans. And so that opens up a whole new line of analysis of comparative genomics where you're comparing human to human to human to human genomes," Dooling says. "This was an analysis that wasn't even feasible two years ago.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.